Table 2 The oncological outcome, renal function, and complications of the patients
Patient No. | F/u period (mo) | Time to recurrence (mo) | Site of recurrence | Pre-operative CKD stage (eGFR, mL/min) | Long-term CKD stage (eGFR, mL/min) | Early complications | Late complications |
|---|---|---|---|---|---|---|---|
1 | 137 | Nil | IV (22.94) | IV (21.27) | Metabolic acidosis | ||
2 | 41 | 12 | Bladder | III (39.51) | II (65.23) | Urine leakage | |
3a | 157 | Nil | II (80.06) | I (106.14) | Urine leakage | ||
4a | 167 | Nil | III (58.26) | III (36.95) | Acute kidney injury | ||
5a | 81 | Nil | IV (27.21) | V (10.88) | Recurrent UTI Metabolic acidosis | ||
6 | 141 | 23 | Bladder | V (12.21) | H/D | Urine leakage Acute kidney injury | Recurrent hematuria |
7b | 56 | 42 | Upper tractc | IV (15.81) | III (32.26) | Recurrent UTI | |
8b | 23 | 12 | Bladder | III (51.47) | III (57.14) | UTI |